TipRanks

Notifications

Tag: PFE

Total 672 Posts

Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bruker (BRKRResearch Report), Inspire Medical Systems (INSPResearch Report) and Pfizer (PFEResearch Report) with bullish sentiments.

Bruker (BRKR)

Bank of America Securities analyst Michael Ryskin maintained a Buy rating on Bruker today and set a price target of $95.00. The company’s shares closed last Thursday at $94.27, close to its 52-week high of $94.86.

According to TipRanks.com, Ryskin is a 3-star analyst with an average return of 5.2% and a 53.9% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, Elanco Animal Health, and Phibro Animal Health.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bruker with a $87.88 average price target.

See today’s best-performing stocks on TipRanks >>

Inspire Medical Systems (INSP)

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Inspire Medical Systems, with a price target of $265.00. The company’s shares closed last Thursday at $195.23.

According to TipRanks.com, Steed is a 4-star analyst with an average return of 9.7% and a 70.3% success rate. Steed covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Tandem Diabetes Care, and Baxter International.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Inspire Medical Systems with a $250.67 average price target, a 25.6% upside from current levels. In a report issued on March 19, Morgan Stanley also initiated coverage with a Buy rating on the stock with a $250.00 price target.

Pfizer (PFE)

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Pfizer. The company’s shares closed last Thursday at $27.66, close to its 52-week low of $25.61.

According to TipRanks.com, Toung is a 5-star analyst with an average return of 9.4% and a 64.8% success rate. Toung covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Charles River Labs, and Silk Road Medical.

Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $31.44.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BRKR: